Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 8 Hematopoietic and Lymphatic System Neoplasm 7 Neoplasms 5 Lung Neoplasms 5 Malignant Solid Neoplasm 4 Colorectal Neoplasms 4 Prostatic Neoplasms 3 Ovarian Neoplasms 3 Hematologic Neoplasms 3 Thyroid Cancer, Papillary 2 Oropharyngeal Neoplasms 2 Multiple Myeloma 2 Mouth Neoplasms 2 Melanoma 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Head and Neck Neoplasms 2 Depression 2 Colonic Neoplasms 2 Carcinoma 2 Anatomic Stage I Breast Cancer AJCC v8 2 Advanced Malignant Solid Neoplasm 2 Adenocarcinoma, Follicular 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Testicular Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Spondylitis, Ankylosing 1 Smoking Cessation 1 Sarcoma 1

Interventions

Gemcitabine 31 pembrolizumab 20 Cisplatin 20 Magnetic Resonance Spectroscopy 18 Specimen Handling 16 durvalumab 11 Mitomycin 11 enfortumab vedotin 9 avelumab 9 Nivolumab 9 Cystoscopy 9 Fluorouracil 8 Radiation 7 Carboplatin 7 Radiotherapy 6 Immunoglobulin G 6 Docetaxel 6 Disulfides 6 Cystectomy 6 Transurethral Resection of Bladder 5 Mitozytrex 5 Biopsy 5 sacituzumab govitecan 4 erdafitinib 4 dehydroftorafur 4 atezolizumab 4 Standard of Care 4 Platinum 4 1,2-diaminocyclohexaneplatinum II citrate 4 tremelimumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Urinary Bladder Neoplasms × Interviews as Topic × 90 days × Clear all

NCT07302230 2026-03-13

EMPOWER

University of Washington

Phase NA Recruiting

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡